Psychoactive drugs are having a moment. The FDA will soon weigh in

MDMA is part of a new wave of psychoactive drugs that show great potential for treating conditions such as severe depression and PTSD.

Related Keywords

United States ,California ,American ,David Olson ,Google Deepmind ,Los Angeles ,Hayim Raclaw ,Lori Tipton ,Davis Institute For Psychedelics ,University Of California ,Institute For Clinical ,Multidisciplinary Association For Psychedelic ,Drug Administration ,California Health Care Foundation ,Johns Hopkins University ,Health News ,Dawn Megli ,New Orleans ,South American ,Lykos Therapeutics ,California Davis Institute ,Substances Act ,Economic Review ,Multidisciplinary Association ,Psychedelic Studies ,Negev Capital ,Del Dosso ,Mindstate Design Labs ,California Healthline ,